Medicare Poised to Add Important HIV Drug to Preventive Service List
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Medicare provides health coverage to over 60 million older adults and people with disabilities, paying for important medical care in hospital and outpatient settings. Nearly 12.5 million beneficiaries also rely on Medicaid, which helps with affordability through the Medicare Savings Programs (MSPs), and covers services Medicare does not, such as long-term services and supports. The Medicare Rights Center supports strengthening Medicare and Medicaid, modernizing benefits and financial assistance, and bolstering the workers and caregivers who deliver this vital care.
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
A new whitepaper from the Brookings Center on Health Policy draws on an array of data sources to identify opportunities
Late last month, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to reduce Medicare coverage
On June 27, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to improve Medicare coverage and affordability. While Medicare Rights applauds this important goal, we are concerned that several of the bills run counter to it. As outlined in the letter, we urged lawmakers to correct those misalignments.
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
This article was written in coordination with the Center for Medicare Advocacy and the Legal Action Center. The New York
When it comes to billing rates, where a Medicare beneficiary receives health care is almost as important as the service
In 2023, the Centers for Medicare & Medicaid Services (CMS) opened a review to determine if Medicare should cover Preexposure
Last week, CMS released additional guidance regarding Medicare Prescription Payment Plan (MPPP) outreach and education. The MPPP, sometimes referred to
A new whitepaper from the Brookings Center on Health Policy draws on an array of data sources to identify opportunities
Late last month, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to reduce Medicare coverage
On June 27, the U.S. House Committee on Ways and Means advanced several bipartisan bills intended to improve Medicare coverage and affordability. While Medicare Rights applauds this important goal, we are concerned that several of the bills run counter to it. As outlined in the letter, we urged lawmakers to correct those misalignments.
The Inflation Reduction Act (IRA) of 2022 made key changes in Medicare law and coverage to improve prescription drug affordability for older adults and people with disabilities. Since its passage, some stakeholders and lawmakers have targeted IRA policies for revision or repeal, especially the law’s Medicare Drug Price Negotiation Program. Depending on the provisions targeted, this would increase beneficiary costs and increase Medicare spending.
This article was written in coordination with the Center for Medicare Advocacy and the Legal Action Center. The New York
When it comes to billing rates, where a Medicare beneficiary receives health care is almost as important as the service